Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCP-AtorFen in Dyslipidemia
NCT00504829Phase 2Completed
- Sponsor
- Veloxis Pharmaceuticals
- Start
- Jul 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LCP-AtorFen in dyslipidemia, sponsored by Veloxis Pharmaceuticals. Started Jul 2007; status: completed.
02
Drugs
LCP-AtorFen
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00504829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504829.